Business Description
HeiLongJiang ZBD Pharmaceutical Co Ltd
ISIN : CNE100002219
Share Class Description:
SHSE:603567: Class ATotal Employee Number:
1,961Compare
Compare
Traded in other countries / regions
603567.China Index Membership
SSE Composite Index IPO Date
2015-04-24Description
HeiLongJiang ZBD Pharmaceutical Co Ltd operates as a pharmaceutical manufacturer. The business scope of the company includes wholesale, retail, traditional Chinese medicine decoction pieces, Chinese medicine formula granules, Chinese herbal medicine trade, medical equipment, sanitary materials, and inspection and testing.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.02 | |||||
Equity-to-Asset | 0.58 | |||||
Debt-to-Equity | 0.52 | |||||
Debt-to-EBITDA | -1.74 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 0.71 | |||||
Beneish M-Score | -3.67 | |||||
WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -42.6 | |||||
3-Year EPS without NRI Growth Rate | -70.2 | |||||
3-Year Book Growth Rate | -4 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 65.28 | |||||
9-Day RSI | 64.45 | |||||
14-Day RSI | 61.1 | |||||
3-1 Month Momentum % | -35.44 | |||||
6-1 Month Momentum % | -48.25 | |||||
12-1 Month Momentum % | -65.65 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.38 | |||||
Quick Ratio | 1.03 | |||||
Cash Ratio | 0.01 | |||||
Days Inventory | 624.56 | |||||
Days Sales Outstanding | 2117.29 | |||||
Days Payable | 130.73 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 2.17 | |||||
3-Year Dividend Growth Rate | 12.3 | |||||
Forward Dividend Yield % | 2.17 | |||||
5-Year Yield-on-Cost % | 2.17 | |||||
Shareholder Yield % | 5.27 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | -72.94 | |||||
Operating Margin % | -142.64 | |||||
Net Margin % | -317.72 | |||||
EBITDA Margin % | -353.59 | |||||
FCF Margin % | 117.94 | |||||
OCF Margin % | 127.85 | |||||
ROE % | -22.99 | |||||
ROA % | -13.95 | |||||
ROIC % | -5.74 | |||||
3-Year ROIIC % | -229.28 | |||||
ROC (Joel Greenblatt) % | -33.07 | |||||
ROCE % | -22.53 | |||||
Years of Profitability over Past 10-Year | 9 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Forward PE Ratio | 8.61 | |||||
Shiller PE Ratio | 23.72 | |||||
PS Ratio | 12.66 | |||||
PB Ratio | 1.06 | |||||
Price-to-Tangible-Book | 1.33 | |||||
Price-to-Free-Cash-Flow | 10.74 | |||||
Price-to-Operating-Cash-Flow | 9.91 | |||||
EV-to-EBIT | -5.32 | |||||
EV-to-EBITDA | -5.32 | |||||
EV-to-Revenue | 18.81 | |||||
EV-to-FCF | 15.95 | |||||
Price-to-GF-Value | 3.56 | |||||
Price-to-Projected-FCF | 7.24 | |||||
Price-to-Median-PS-Value | 3.53 | |||||
| Price-to-Net-Current-Asset-Value | 10.12 | |||||
Earnings Yield (Greenblatt) % | -18.8 | |||||
FCF Yield % | 9.31 | |||||
Forward Rate of Return (Yacktman) % | -28.11 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
HeiLongJiang ZBD Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 510.445 | ||
| EPS (TTM) (Â¥) | -1.725 | ||
| Beta | 0.8951 | ||
| 3-Year Sharpe Ratio | -1.15 | ||
| 3-Year Sortino Ratio | -1.21 | ||
| Volatility % | 42.06 | ||
| 14-Day RSI | 61.1 | ||
| 14-Day ATR (Â¥) | 0.527167 | ||
| 20-Day SMA (Â¥) | 5.252 | ||
| 12-1 Month Momentum % | -65.65 | ||
| 52-Week Range (Â¥) | 4.21 - 13.48 | ||
| Shares Outstanding (Mil) | 940.24 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
HeiLongJiang ZBD Pharmaceutical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
HeiLongJiang ZBD Pharmaceutical Co Ltd Stock Events
| Event | Date | Price (Â¥) | ||
|---|---|---|---|---|
| CNY 0.150000 Cash Dividend | 2025-08-20 | 12.44 (-1.27%) | ||
| 2:1 Stock Split | 2016-06-13 | 25.00 (-1.98%) |
Show
Entries
HeiLongJiang ZBD Pharmaceutical Co Ltd Frequently Asked Questions
What is HeiLongJiang ZBD Pharmaceutical Co Ltd(SHSE:603567)'s stock price today?
The current price of SHSE:603567 is ¥6.88. The 52 week high of SHSE:603567 is ¥13.48 and 52 week low is ¥4.21.
When is next earnings date of HeiLongJiang ZBD Pharmaceutical Co Ltd(SHSE:603567)?
The next earnings date of HeiLongJiang ZBD Pharmaceutical Co Ltd(SHSE:603567) is .
Does HeiLongJiang ZBD Pharmaceutical Co Ltd(SHSE:603567) pay dividends? If so, how much?
The Dividend Yield %  of HeiLongJiang ZBD Pharmaceutical Co Ltd(SHSE:603567) is 2.17% (As of Today), Highest Dividend Payout Ratio of HeiLongJiang ZBD Pharmaceutical Co Ltd(SHSE:603567) was 0.6. The lowest was 0.06. And the median was 0.44. The  Forward Dividend Yield % of HeiLongJiang ZBD Pharmaceutical Co Ltd(SHSE:603567) is 2.17%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on HeiLongJiang ZBD Pharmaceutical Co Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers